glp 1 receptor agonists beyond their pancreatic effects GLP-1 and health: weight loss in the Ozempic era GLP-1 Receptor Agonists | New

Will a higher dose of BPC-157 give me better results? In the more is better culture of fitness and biohacking, its easy to assume doubling the dose doubles the recovery speed

The apparent activation of the GHS-R1a receptor by Ipamorelin may lead to increased intracellular calcium ions through the phospholipase C pathway

It has been found to reduce melanin production, leading to a brighter and more even skin tone

A comprehensive 2025 analysis published in the Proceedings of the National Academy of Sciences (PNAS) evaluated patient-reported outcomes for various treatments in post-viral dysautonomia and ME/CFS cohorts

While treatments like fillers and surgery still have their place, peptide therapy may offer a more regenerative and holistic approach

Machine learning in predicting graft failure following kidney transplantation: a systematic review of published predictive models